Stay updated on Margetuximab Combo in Chinese HER2+ MBC Clinical Trial
Sign up to get notified when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.

Latest updates to the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page
- Check4 days agoChange DetectedA new revision entry Revision: v3.3.3 was added to the Study Record History; the HHS Vulnerability Disclosure link was removed and Revision: v3.3.2 is no longer listed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe record history shows a new revision (v3.3.2) and the removal of an older revision (v3.2.0) for the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe Notice about government funding and operating status was removed from the page, a minor change that does not affect study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check54 days agoChange DetectedRecruitment status updated to Active, not recruiting. Last update posted on 2023-08-22.SummaryDifference0.1%

- Check83 days agoChange DetectedCore content updated to inform users about funding-related operating status and current NIH Clinical Center openness; version updated from v3.1.0 to v3.2.0.SummaryDifference13%

- Check90 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to Margetuximab Combo in Chinese HER2+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.